Page 219 - 2021_12-Haematologica-web

Letters to the Editor
doi:10.3324/haematol.2021.278827
Received: March 23, 2021.
Accepted: September 8, 2021.
Pre-published: September 16, 2021.
Disclosures: no conflicts of interest to disclose.
Contributions: MF and AE collected, analyzed, and interpreted
the data; AE and MF drafted the manuscript; MF, AE and GV contributed to the study conception and design; FV, AT and CV performed investigation of S. aureus strains; MF, GV, FL, FV, CV and AT critically revised the manuscript. All the authors read and approved the final manuscript.
References
1. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25):1855-1865.
2. Cecchini J, Boissier F, Gibelin A, et al. Pulmonary vascular dysfunction and cor pulmonale during acute respiratory distress syndrome in sicklers. Shock. 2016;46(4):358-364.
3. Charache S, Scott JC, Charache P. “Acute chest syndrome” in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med. 1979;139(1):67-69.
4. Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus com- munity-acquired pneumonia: prevalence, clinical characteristics, and out- comes. Clin Infect Dis. 2016;63(3):300-309.
5. Habibi A, Arlet J-B, Stankovic K, et al. [French guidelines for the manage- ment of adult sickle cell disease: 2015 update]. Rev Med Interne. 2015; 36(5 Suppl 1):S5S3-84.
6. Soothill G, Darboe S, Bah G, Bolarinde L, Cunnington A, Anderson ST. Invasive bacterial infections in Gambians with sickle cell anemia in an era of widespread pneumococcal and hemophilus influenzae type b vaccina- tion. Medicine (Baltimore). 2016;95(49):e5512.
7. Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol. 2013;21(3):129-135.
8. Spijkerman J, Prevaes SMPJ, van Gils EJM, et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneu- moniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One. 2012;7(6):e39730.
9. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344(1):11-16.
10. Paling FP, Hazard D, Bonten MJM, et al. Association of Staphylococcus aureus colonization and pneumonia in the intensive care unit. JAMA Netw Open. 2020;3(9):e2012741.
11. Rocha LC, Carvalho MOS, Nascimento VML, et al. Nasopharyngeal and oropharyngeal colonization by Staphylococcus aureus and Streptococcus pneumoniae and prognostic markers in children with sickle cell disease from the Northeast of Brazil. Front Microbiol. 2017;8:217.
12. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus communi- ty-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53(3):358-365.
13. Gillet Y, Tristan A, Rasigade J-P, et al. Risk factors of severity in commu- nity-acquired staphylococcal pneumonia. MedRxiv. 2020:20162875. 14.Schaumburg F, Biallas B, Alabi AS, et al. Clonal structure of
Staphylococcus aureus colonizing children with sickle cell anaemia and
healthy controls. Epidemiol Infect. 2013;141(8):1717-1720.
15. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfolia- tive toxins among strains of Staphylococcus aureus isolated from blood
and nasal specimens. J Clin Microbiol. 2003;41(4):1434-1439.
haematologica | 2021; 106(12)
3239